33 / 64
31
PROGRAMME & EXHIBITION GUIDE |
POSTERS
Predictive and prognostic value of pretreatment FDG-PET SUV parameters
in head and neck
L. Deantonio (Italy), M. Paolini, E. Puta, E. Ferrara, L. Vigna, R. Matheoud,
G. Sacchetti, M. Brambilla, M. Krengli
PO-076
Cisplatin or Carboplatin in locally advanced head and neck squamous cell
carcinoma
Abstract withdrawn
PO-077
Poster
Innovative treatments
The evaluation of the set-up differences between radiation therapists for
head and neck patients
E. Kara (Turkey), A. Yazici, B. Dirican, B. Boybas, M.A. Gunaydin, A. Kartal,
M. Akmansu, A. Hicsonmez
PO-078
Hypofractionated versus prolonged chemo-IMRT schedules in
oropharyngeal carcinoma
I. Boon (UK), C. Boon, P. Nightingale, J. Cashmore, G. Sangha, M. Hickman,
H. Benghiat, C. Fong, P. Sanghera, A. Hartley
PO-079
Challenges and opportunities in head and neck cancer research in the UK:
a survey of oncologists
B. Foran (UK), J. Fenwick, B. Byrne, J. Christian
PO-080
Recurrence analysis in head and neck squamous cell carcinoma treated
with adjuvant EUD-based IMRT
S. Welz (Germany), T. Schönle, D. Thorwarth, D. Zips
PO-081
Correlation between HI, GI, CI and size of metastases for linac-based high
dose SRT / SRS
B. Tas (Turkey), I.F. Durmus, A. Okumus, O.E. Uzel
PO-082
Adaptative radiotherapy for nasopharyngeal carcinoma
L. Farhat (Tunisia), W. Mnejja, T. Sahnoun, F. Dhouib, J. Daoud
PO-083
HDR interstitial brachytherapy for head and neck malignancies with
Iridium 192 implants
V. Pareek (India), R. Bhalavat, M. Chandra
PO-084